People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Fog Pharmaceuticals, Inc. | — | Pharmaceuticals | Series D+ | $278.4M | $3.1B | 2016 |
Michael L Aceti at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael L Aceti on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Corey S. Goodman | 1 | 4 |
| Gregory L Verdine | 1 | 3 |
| WeiQing L Zhou | 1 | 2 |
| Leon M. Chen | 1 | 2 |
| Leon A. Chen | 1 | 2 |
| Edward M. Fitzgerald | 1 | 1 |
| Barbara M. Weber | 1 | 1 |
| WeiQing A. Zhou | 1 | 1 |
| Edward A. Fitzgerald | 1 | 1 |
| WeiQing M. Zhou | 1 | 1 |
| Krishna M. Yeshwant | 1 | 1 |
| Rick M. Klausner | 1 | 1 |
| Jeffrey A. Leerink | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.